Sign In

Bill Bedell

Business Development at the Wyss Institute

Bill Bedell, Ph.D., is the Business Development Manager at the Wyss Institute for Biologically Inspired Engineering at Harvard University. He joined the institute in 2021.1 In his role, Bill works closely with the scientists, engineers, and staff to translate advanced technologies into commercial ventures.1

Prior to joining the Wyss Institute, Bill served as a strategy consultant to life sciences companies, ranging from biotechnology startups to Fortune 500 pharmaceutical firms.1 His expertise lies in bridging the gap between academic research and industrial applications.

Bill is actively involved in various projects at the Wyss Institute, including:

  1. The AminoX platform, which aims to create safer immune checkpoint inhibitor protein drugs for cancer treatment.2
  2. The ViroScreen project, exploring diverse viruses for novel RNA delivery methods.2
  3. The HarborSite technology, which focuses on precise and efficient gene editing for next-generation gene therapies.4

On his LinkedIn profile, Bill describes himself as passionate about solving tough problems and emphasizes the Wyss Institute's commitment to tackling high-risk, high-reward challenges in healthcare and biotechnology.3

Related Questions

What are some of the key projects Bill Bedell has worked on at the Wyss Institute?
How does Bill Bedell's background in chemical engineering influence his work in business development?
What is the significance of the Validation Projects at the Wyss Institute?
How does the Wyss Institute translate deep technologies into commercial ventures?
What are some examples of successful technology commercialization at the Wyss Institute?
Bill Bedell
Bill Bedell, photo 1
Bill Bedell, photo 2
Add to my network

Location

Boston, Massachusetts, United States